Autek China Inc
SZSE:300595

Watchlist Manager
Autek China Inc Logo
Autek China Inc
SZSE:300595
Watchlist
Price: 15.05 CNY -2.78% Market Closed
Market Cap: 13.5B CNY

Autek China Inc
Free Cash Flow

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Autek China Inc
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
Autek China Inc
SZSE:300595
Free Cash Flow
¥536m
CAGR 3-Years
-1%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Free Cash Flow
¥2.6B
CAGR 3-Years
-2%
CAGR 5-Years
3%
CAGR 10-Years
N/A
S
Shanghai Conant Optical Co Ltd
HKEX:2276
Free Cash Flow
¥261.8m
CAGR 3-Years
134%
CAGR 5-Years
49%
CAGR 10-Years
N/A
Winner Medical Co Ltd
SZSE:300888
Free Cash Flow
¥364.9m
CAGR 3-Years
42%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
Free Cash Flow
¥917.2m
CAGR 3-Years
29%
CAGR 5-Years
13%
CAGR 10-Years
23%
Intco Medical Technology Co Ltd
SZSE:300677
Free Cash Flow
-¥1B
CAGR 3-Years
-13%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Autek China Inc
Glance View

Market Cap
13.5B CNY
Industry
Health Care

Autek China Inc. stands as an emblematic figure in the dynamic landscape of medical devices and biotechnology in China. Rooted in its mission to innovate within the realms of diagnostic imaging and therapeutic ultrasound equipment, the company has maneuvered through this niche market by leveraging both cutting-edge technology and strategic partnerships. Autek's portfolio includes a range of high-quality ultrasound machines and imaging solutions that cater to the rapidly evolving needs of hospitals and clinics. By capitalizing on the growing demand for advanced healthcare services in China, Autek has tailored its product offerings to resonate with local market needs while maintaining competitive pricing strategies. This keen understanding of market dynamics allows Autek to maintain a robust sales pipeline and forge sturdy relationships within the medical community, driving its revenue growth engine. The company's operational blueprint hinges on an impressive blend of research-driven innovation and effective distribution networks. Autek continually invests in research and development, aspiring to push technological boundaries and uphold its reputation as a pioneer in the medical imaging sector. This investment lays the groundwork for creating state-of-the-art products that are not only technologically advanced but also user-friendly for medical professionals. Autek's adeptness at navigating regulatory landscapes ensures smooth market entry and expansion for its offerings. Furthermore, its strategic alliances with healthcare providers and government entities enhance its distribution network, ensuring that its products reach a wide spectrum of healthcare institutions across China. Autek makes its money by selling its technologically advanced and reliable devices, as well as providing ongoing support and maintenance services, forming the backbone of its revenue model and securing its position in the competitive arena.

Autek China Inc Intrinsic Value
HIDDEN
Show

See Also

What is Autek China Inc's Free Cash Flow?
Free Cash Flow
536m CNY

Based on the financial report for Sep 30, 2025, Autek China Inc's Free Cash Flow amounts to 536m CNY.

What is Autek China Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
18%

Over the last year, the Free Cash Flow growth was 9%. The average annual Free Cash Flow growth rates for Autek China Inc have been -1% over the past three years , 18% over the past five years .

Back to Top